Hemant Kumar
Keine laufenden Positionen mehr
Vermögen: 10 600 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Hemant Kumar
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Hemant Kumar
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Aronex Pharmaceuticals, Inc.
 Aronex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aronex Pharmaceuticals, Inc. develops proprietary medicines to treat cancer and infectious diseases. The company's products include Nyotran, Atragen, Annamycin, and Zintevir. It is headquartered in The Woodlands, TX. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| REPROS THERAPEUTICS INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Corporate Officer/Principal | |
| BOTANIX PHARMACEUTICALS LIMITED | Pharmaceuticals: Major | Chief Executive Officer | |
| University of Missouri | College/University | Undergraduate Degree | |
| Texas A&M University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Phoenix | College/University | Masters Business Admin | |
| Virginia Commonwealth University | College/University | Doctorate Degree | |
| Wesleyan University | College/University | Undergraduate Degree | |
Gemin X Pharmaceuticals US, Inc.
 Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | Biotechnology | Corporate Officer/Principal | |
| Baylor College of Medicine | College/University | Corporate Officer/Principal | |
| Licensing Executives Society | Corporate Officer/Principal | ||
Biovail Pharmaceuticals LLC
 Biovail Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Biovail Pharmaceuticals, Inc. researches and develops pharmaceutical medicines. The company products include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. The company is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Kuur Therapeutics Ltd.
 Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Deciphera Pharmaceuticals LLC
 Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Kadmon Corp. LLC
 Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| ACTINIUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| The University of Virginia School of Medicine | College/University | Doctorate Degree | |
| ONCOLIX, INC. | Pharmaceuticals: Major | Chief Executive Officer |
Statistik
International
| Vereinigte Staaten | 22 |
| Vereinigtes Königreich | 3 |
| Australien | 2 |
Sektoral
| Health Technology | 16 |
| Consumer Services | 9 |
| Commercial Services | 2 |
Operativ
| Corporate Officer/Principal | 10 |
| Chief Tech/Sci/R&D Officer | 7 |
| Chief Executive Officer | 5 |
| Undergraduate Degree | 5 |
| Director/Board Member | 3 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Michael T. Redman | 13 |
| Mark Berger | 10 |
| Shannon Inman | 4 |
| Kate Combs | 2 |
| Suzanne Thornton-Jones | 2 |
- Börse
- Insiders
- Hemant Kumar
- Unternehmensverbindungen
